loading

Capricor Therapeutics Inc Stock (CAPR) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
59.41%
4.9069
12.09 6.1858 3.9175 2.9867
Operating Expenses
13.49%
15.17
13.37 13.05 11.66 11.17
Benefits Costs and Expenses
14.40%
14.70
12.85 - - 10.75
Costs And Expenses
14.40%
14.70
12.85 13.05 11.66 10.75
Operating Income/Loss
701.21%
-10.27
-1.2813 -6.8646 -7.7473 -8.1847
Nonoperating Income/Loss
9.12%
0.4718
0.5192 0.474 0.3807 0.4164
Income/Loss From Continuing Operations Before Tax
1,185%
-9.7941
-0.7621 6.1858 -7.3666 -7.7683
Income/Loss From Continuing Operations After Tax
1,185%
-9.7941
-0.7621 -6.3906 -7.3666 -7.7683
Net Income/Loss
1,185%
-9.7941
-0.7621 -6.3906 -7.3666 -7.7683
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,294%
31.35
1.3095 25.82 25.34 25.25
Diluted Average Shares
2,294%
31.35
1.3095 25.82 25.34 25.25
Basic Earnings Per Share
1,650%
-0.31
0.02 -0.25 -0.29 -0.31
Diluted Earnings Per Share
1,650%
-0.31
0.02 -0.25 -0.29 -0.31
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):